Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovodak in patients with hepatitis C and HIV-1
IRCT20180924041107N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sofosbuvir + daclatasvir in hepatitis C virus infection and human immunodeficiency virus infection (HIV), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Viral load. Started Aug 2018; status: completed.
02
Drugs
sofosbuvir + daclatasvir
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on IRCT20180924041107N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180924041107N1.